|4Jan 23, 6:38 PM ET

Feder Julie B 4

4 · Aura Biosciences, Inc. · Filed Jan 23, 2023

Insider Transaction Report

Form 4
Period: 2023-01-19
Feder Julie B
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2023-01-19+48,75072,985 total
  • Award

    Stock Option (Right to Buy)

    2023-01-19+75,00075,000 total
    Exercise: $10.18Exp: 2033-01-18Common Stock (75,000 underlying)
Footnotes (2)
  • [F1]These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on the one year anniversary of the date of grant.
  • [F2]The shares underlying this option vest as follows: 25% of the shares vest on the first anniversary of January 19, 2023 with the remainder vesting thereafter pro-rata in 36 monthly installments.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION